14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:INFI
Delisted

Infinity Pharmaceuticals Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0160
+0 (+0%)
At Close: Dec 28, 2023
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0160 $0.0160 Thursday, 28th Dec 2023 INFI stock ended at $0.0160. During the day the stock fluctuated 0% from a day low at $0.0160 to a day high of $0.0160.
90 days $0.0115 $0.0190
52 weeks $0.0111 $0.770

Historical Infinity Pharmaceuticals prices

Date Open High Low Close Volume
Apr 19, 2023 $0.175 $0.185 $0.160 $0.171 834 004
Apr 18, 2023 $0.166 $0.189 $0.161 $0.174 1 000 269
Apr 17, 2023 $0.162 $0.184 $0.155 $0.163 1 629 178
Apr 14, 2023 $0.157 $0.164 $0.150 $0.158 1 549 246
Apr 13, 2023 $0.147 $0.160 $0.142 $0.151 743 529
Apr 12, 2023 $0.152 $0.165 $0.141 $0.142 1 265 022
Apr 11, 2023 $0.155 $0.170 $0.155 $0.155 905 961
Apr 10, 2023 $0.148 $0.160 $0.145 $0.155 585 899
Apr 06, 2023 $0.121 $0.157 $0.119 $0.148 2 084 376
Apr 05, 2023 $0.140 $0.145 $0.135 $0.137 924 551
Apr 04, 2023 $0.150 $0.151 $0.140 $0.146 1 000 902
Apr 03, 2023 $0.151 $0.160 $0.140 $0.146 1 683 747
Mar 31, 2023 $0.170 $0.180 $0.145 $0.160 2 949 399
Mar 30, 2023 $0.190 $0.200 $0.177 $0.180 1 133 461
Mar 29, 2023 $0.187 $0.196 $0.183 $0.190 352 424
Mar 28, 2023 $0.194 $0.204 $0.180 $0.193 931 150
Mar 27, 2023 $0.200 $0.200 $0.183 $0.183 565 976
Mar 24, 2023 $0.180 $0.204 $0.180 $0.200 1 005 465
Mar 23, 2023 $0.196 $0.216 $0.175 $0.192 3 373 723
Mar 22, 2023 $0.203 $0.210 $0.195 $0.200 340 914
Mar 21, 2023 $0.191 $0.219 $0.188 $0.202 913 315
Mar 20, 2023 $0.190 $0.199 $0.185 $0.191 285 540
Mar 17, 2023 $0.200 $0.200 $0.184 $0.185 393 454
Mar 16, 2023 $0.189 $0.198 $0.182 $0.198 410 405
Mar 15, 2023 $0.202 $0.202 $0.180 $0.182 433 344
Click to get the best stock tips daily for free!

About Infinity Pharmaceuticals

Infinity Pharmaceuticals Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the tre... INFI Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT